Literature DB >> 8404914

Effect of alkalinisation and increased fluid intake on bacterial phagocytosis and killing in urine.

R A Gargan1, J M Hamilton-Miller, W Brumfitt.   

Abstract

The effect of alkalinisation and increased fluid intake on bacterial phagocytosis and killing in urine was studied. Phagocytosis of Escherichia coli and Staphylococcus saprophyticus by polymorphonuclear neutrophils (PMN) took place in only one of three first voided early morning urine samples from volunteers, and no bacterial killing occurred. This was attributed to the high osmolality (690 to 720 mOsm) and low pH of the early morning urine; two samples were pH 5.8 and the third, in which phagocytosis occurred, was pH 6.4. Afternoon urine samples from the same volunteers had lower osmolality and a higher pH, with a high rate of phagocytosis (> or = 88%) and 55-69% killing. PMN remained viable (mean 94%) after exposure for 1 h to both early morning and afternoon urine. Volunteers taking 4 g sodium citrate showed a mean rise of urinary pH of 1 unit. Water loading in patients with urinary tract infections produced a bacteria to neutrophil ratio conducive to bacterial killing, bacterial counts being reduced by a mean of 2.5 logs after 1-3 h without a corresponding reduction in neutrophils. Thus, raising the pH and reducing the osmolality of urine increases the ability of neutrophils to eliminate infecting organisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404914     DOI: 10.1007/bf01970959

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  Depression of phagocytosis by solutes in concentrations found in the kidney and urine.

Authors:  I CHERNEW; A I BRAUDE
Journal:  J Clin Invest       Date:  1962-10       Impact factor: 14.808

2.  Diurnal variation in electrolyte excretion.

Authors:  S W STANBURY; A E THOMSON
Journal:  Clin Sci       Date:  1951-08       Impact factor: 6.124

3.  Failure of water to lyse polymorphonuclear neutrophils completely. Role of pH and implications for assessment of bacterial killing.

Authors:  R A Gargan; W Brumfitt; J M Hamilton-Miller
Journal:  J Immunol Methods       Date:  1989-11-30       Impact factor: 2.303

4.  ALKALINE TIDES.

Authors:  G D Barnett; F E Blume
Journal:  J Clin Invest       Date:  1938-03       Impact factor: 14.808

5.  Studies on the phagocytic function of urinary leukocytes.

Authors:  S Maeda; T Deguchi; Y Kanimoto; M Kuriyama; Y Kawada; T Nishiura
Journal:  J Urol       Date:  1983-02       Impact factor: 7.450

6.  Cytochrome staining of leukocytes in urine sediment. Assessment of inflammatory state.

Authors:  W P Guthinger; K Pranikoff; A T Cockett
Journal:  Urology       Date:  1977-06       Impact factor: 2.649

7.  Urinary neutrophil chemotactic factors in interstitial cystitis patients and a rabbit model of bladder inflammation.

Authors:  S A Elgebaly; M E Allam; M P Walzak; D Oselinsky; C Gillies; H Yamase
Journal:  J Urol       Date:  1992-05       Impact factor: 7.450

8.  Urinary IgG antibody against mixed heat-killed coliform antigen and lipopolysaccharide core antigen.

Authors:  A P Gibb; D M Edmond
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

9.  Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

10.  Alkalinisation in the management of cystitis.

Authors:  J B Spooner
Journal:  J Int Med Res       Date:  1984       Impact factor: 1.671

View more
  2 in total

1.  A pilot randomized study on use of oral acetazolamide in patients with refractory dysuria.

Authors:  Morteza Hamidi; Seyed Mohammad Kazem Aghamir; Alborz Salavati; Ahmad Masoomi
Journal:  Int Urol Nephrol       Date:  2017-03-13       Impact factor: 2.370

2.  Cyanate-mediated inhibition of neutrophil myeloperoxidase activity.

Authors:  M Qian; J W Eaton; S P Wolff
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.